Oncogenic and tumor suppressor function of MEIS and associated factors

MEIS proteins are historically associated with tumorigenesis, metastasis, and invasion in cancer. MEIS and associated PBX-HOX proteins may act as tumor suppressors or oncogenes in different cellular settings. Their expressions tend to be misregulated in various cancers. Bioinformatic analyses have suggested their upregulation in leukemia/lymphoma, thymoma, pancreas, glioma, and glioblastoma, and downregulation in cervical, uterine, rectum, and colon cancers. However, every cancer type includes, at least, a subtype with high MEIS expression. In addition, studies have highlighted that MEIS proteins and associated factors may function as diagnostic or therapeutic biomarkers for various diseases. Herein, MEIS proteins and associated factors in tumorigenesis are discussed with recent discoveries in addition to how they could be modulated by noncoding RNAs or newly developed small-molecule MEIS inhibitors.

___

  • Aamar E, 2004, DEVELOPMENT, V131, P153, DOI 10.1242/dev.00905
  • Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907
  • Abbaszadegan MR, 2018, PATHOL ONCOL RES, V24, P245, DOI 10.1007/s12253-017-0243-1
  • Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295
  • Aksoz M, 2018, CURR DRUG TARGETS, V19, P181, DOI 10.2174/1389450118666170724165514
  • Alvarado-Ruiz Liliana, 2016, Asian Pac J Cancer Prev, V17, P1037
  • Ando H, 2014, CANCER CHEMOTH PHARM, V73, P53, DOI 10.1007/s00280-013-2316-5
  • Xavier FCA, 2014, ARCH ORAL BIOL, V59, P783, DOI 10.1016/j.archoralbio.2014.05.001
  • Argani P, 2018, AM J SURG PATHOL, V42, P1562, DOI 10.1097/PAS.0000000000001140
  • Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001
  • Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343
  • Aulisa L, 2009, ACTA BIOMATER, V5, P842, DOI 10.1016/j.actbio.2008.11.002
  • Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004
  • Bach DH, 2018, CANCER LETT, V419, P152, DOI 10.1016/j.canlet.2018.01.053
  • Bakkum-Gamez JN, 2015, GYNECOL ONCOL, V137, P14, DOI 10.1016/j.ygyno.2015.01.552
  • Bell A, 2011, CANCER-AM CANCER SOC, V117, P2898, DOI 10.1002/cncr.25818
  • Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106
  • Berrondo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147236
  • Beukers W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077657
  • Beukers W, 2013, J UROLOGY, V190, P311, DOI 10.1016/j.juro.2013.01.078
  • Bhanvadia RR, 2018, CLIN CANCER RES, V24, P3668, DOI 10.1158/1078-0432.CCR-17-3673
  • Bhatlekar S, 2018, J CELL PHYSIOL, V233, P727, DOI 10.1002/jcp.25981
  • Blasi F, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600245
  • Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
  • Calle AS, 2018, CANCER SCI, V109, P2093, DOI 10.1111/cas.13642
  • Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377
  • Cantile M, 2003, ONCOGENE, V22, P6462, DOI 10.1038/sj.onc.1206808
  • Cantile M, 2013, INT J MOL SCI, V14, P21727, DOI 10.3390/ijms141121727
  • Care A, 1996, MOL CELL BIOL, V16, P4842 .
  • Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008
  • Carrera M, 2015, INT J CLIN EXP PATHO, V8, P3613
  • CARROLL AJ, 1984, BLOOD, V63, P721 .
  • Chang CJ, 2017, J CANCER, V8, P1071, DOI 10.7150/jca.17295
  • Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679
  • Chen FH, 2011, MED ONCOL, V28, P1201, DOI 10.1007/s12032-010-9634-9
  • Chen GX, 2018, ONCOTARGETS THER, V11, DOI 10.2147/OTT.S152362
  • Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373
  • Chen QY, 2019, CARCINOGENESIS, V40, P393, DOI 10.1093/carcin/bgz020
  • Chen R, 2017, NEUROTHERAPEUTICS, V14, P284, DOI 10.1007/s13311-017-0519-x
  • Chen YC, 2015, TAIWAN J OBSTET GYNE, V54, P572, DOI 10.1016/j.tjog.2015.08.010
  • Cheng YT, 2015, ONCOTARGET, V6, P10840, DOI 10.18632/oncotarget.3450
  • Choe SK, 2002, DEVELOPMENT, V129, P585 .
  • Chong GO, 2017, CANCER GENOM PROTEOM, V14, P137, DOI 10.21873/cgp.20026
  • Co M, 2020, WIRES DEV BIOL, V9, DOI 10.1002/wdev.375
  • Collins CT, 2016, CURR OPIN HEMATOL, V23, P354, DOI 10.1097/MOH.0000000000000245
  • Comacchio GM, 2019, THORAC SURG CLIN, V29, P203, DOI 10.1016/j.thorsurg.2018.12.007
  • Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025
  • Crist RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023665
  • Cui L, 2014, EXP CELL RES, V328, P58, DOI 10.1016/j.yexcr.2014.08.023
  • Dancsok AR, 2017, ONCOTARGET, V8, P7068, DOI 10.18632/oncotarget.12548
  • Dard A, 2018, CELL REP, V22, P3058, DOI 10.1016/j.celrep.2018.02.070
  • Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111
  • de Weille J, 2014, INT J BRAIN SCI, V2014, P1
  • Decker B, 2014, PHARMACOGN PERS MED, V7, P193, DOI 10.2147/PGPM.S38117
  • Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528
  • Deramaudt TB, 2006, J BIOL CHEM, V281, P38385, DOI 10.1074/jbc.M605891200
  • Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715
  • Di Zanni E, 2015, EXP CELL RES, V336, P43, DOI 10.1016/j.yexcr.2015.03.025
  • Dihal AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079898
  • Doolan P, 2009, TUMOR BIOL, V30, P200, DOI 10.1159/000239795
  • Drosopoulos Konstantinos, 2019, Methods Mol Biol, V1953, P33, DOI 10.1007/978-1-4939-9145-7_3
  • Du J, 2015, ONCOL REP, V34, P585, DOI 10.3892/or.2015.4023
  • Duan R, 2015, ONCOTARGET, V6, P27778, DOI 10.18632/oncotarget.4813
  • Dudek P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001859
  • Errico MC, 2013, INT J CANCER, V133, P879, DOI 10.1002/ijc.28097
  • Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597
  • Feng XY, 2015, MOL BIOSYST, V11, P2946, DOI 10.1039/c5mb00253b
  • Feng XF, 2017, ONCOTARGET, V8, P63605, DOI 10.18632/oncotarget.18868
  • Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418
  • Fu ZQ, 2017, CANCER LETT, V410, P68, DOI 10.1016/j.canlet.2017.09.019
  • Fujino T, 2001, EXP HEMATOL, V29, P856, DOI 10.1016/S0301-472X(01)00655-5
  • Gajula RP, 2013, MOL CANCER RES, V11, P1387, DOI 10.1158/1541-7786.MCR-13-0218-T
  • Gao L, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12096
  • Garcia-Cuellar MP, 2015, HAEMATOLOGICA, V100, P905, DOI 10.3324/haematol.2015.124032
  • Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9
  • Grebbin BM, 2016, DEVELOPMENT, V143, P2281, DOI 10.1242/dev.128033
  • Grubach L, 2008, EUR J HAEMATOL, V81, P112, DOI 10.1111/j.1600-0609.2008.01083.x
  • Gu SX, 2017, SPINE, V42, P291, DOI 10.1097/BRS.0000000000000889
  • Guan Y, 2019, J DRUG TARGET, V27, P60, DOI 10.1080/1061186X.2018.1473408
  • Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006
  • Guo YB, 2016, ONCOL LETT, V11, P75, DOI 10.3892/ol.2015.3893
  • Han BJ, 2019, INT J BIOL MACROMOL, V125, P544, DOI 10.1016/j.ijbiomac.2018.12.075
  • Han HB, 2014, WORLD J GASTROENTERO, V20, P18260, DOI 10.3748/wjg.v20.i48.18260
  • Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285
  • Hau AC, 2017, J CELL BIOL, V216, P2715, DOI 10.1083/jcb.201701154
  • Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005
  • Higashi K, 2016, ANN NUCL MED, V30, P708, DOI 10.1007/s12149-016-1116-5
  • Hirayama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089885
  • Hu HY, 2017, WIEN KLIN WOCHENSCHR, V129, P391, DOI 10.1007/s00508-016-1108-4
  • Hu LL, 2014, FERTIL STERIL, V102, P856, DOI 10.1016/j.fertnstert.2014.05.036
  • Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006
  • Hung YC, 2003, CANCER SCI, V94, P437, DOI 10.1111/j.1349-7006.2003.tb01461.x
  • Jacques C, 2013, J CLIN ENDOCR METAB, V98, pE981, DOI 10.1210/jc.2012-4006
  • Jeong JH, 2017, MOL CELL, V65, P154, DOI 10.1016/j.molcel.2016.11.034
  • Jia YL, 2018, INT J DEV BIOL, V62, P865, DOI 10.1387/ijdb.180286fb
  • Johng D, 2019, PROSTATE, V79, P414, DOI 10.1002/pros.23747
  • Jones TA, 2000, EUR J CANCER, V36, P2368, DOI 10.1016/S0959-8049(00)00332-4
  • Ju TF, 2017, MOL MED REP, V16, P3194, DOI 10.3892/mmr.2017.6986
  • Jung JG, 2016, CANCER RES, V76, P6351, DOI 10.1158/0008-5472.CAN-16-0980
  • Kanai M, 2010, ONCOL REP, V23, P843, DOI 10.3892/or_00000706
  • Karapetsas A, 2018, MOL CARCINOGEN, V57, P1251, DOI 10.1002/mc.22840
  • Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q
  • Kempinska K, 2018, MOL CANCER THER, V17, P26, DOI 10.1158/1535-7163.MCT-17-0580
  • Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443
  • Kim Jin Wook, 2014, Genes Cancer, V5, P165
  • Kim KT, 2018, WORLD NEUROSURG, V118, pE906, DOI 10.1016/j.wneu.2018.07.096
  • Kitchen MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137003
  • Ko Song Yi, 2014, Cancer Cell Microenviron, V1, pe379
  • Ko SY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-170
  • Ko SY, 2012, J CLIN INVEST, V122, P3603, DOI 10.1172/JCI62229
  • Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260
  • Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84
  • Koller K, 2014, PEDIATR DEVEL PATHOL, V17, P169, DOI 10.2350/13-01-1288-OA.1
  • Lasa A, 2004, LEUKEMIA, V18, P1231, DOI 10.1038/sj.leu.2403377
  • Laurent A, 2008, INT J DEV BIOL, V52, P9, DOI 10.1387/ijdb.072304al
  • Li HF, 2019, FUTURE ONCOL, V15, P1577, DOI 10.2217/fon-2018-0575
  • Li HF, 2017, ONCOTARGETS THER, V10, P5685, DOI 10.2147/OTT.S150139
  • Li J, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S84687
  • Li J, 2015, TUMOR BIOL, V36, P1661, DOI 10.1007/s13277-014-2765-4
  • Li Q, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171563
  • Li Q, 2019, BIOCHEM BIOPH RES CO, V512, P558, DOI 10.1016/j.bbrc.2019.03.124
  • Li WH, 2014, J THORAC DIS, V6, P850, DOI 10.3978/j.issn.2072-1439.2014.06.03
  • Li YB, 2019, EUR REV MED PHARMACO, V23, P2020, DOI 10.26355/eurrev_201903_17241
  • Lin C, 2018, INT J MOL MED, V41, P2050, DOI 10.3892/ijmm.2018.3382
  • Lin C, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8120231
  • Lin LH, 2019, NUCLEIC ACIDS RES, V47, P1255, DOI 10.1093/nar/gky1207
  • Liu H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020200
  • Liu JY, 2010, P NATL ACAD SCI USA, V107, P20494, DOI 10.1073/pnas.1007001107
  • Liu N, 2018, MOL MED REP, V18, P1155, DOI 10.3892/mmr.2018.9020
  • Liu Y, 2019, J BIOL CHEM, V294, P4572, DOI 10.1074/jbc.RA118.006057
  • Liu YL, 2019, INT J ONCOL, V54, P1809, DOI 10.3892/ijo.2019.4735
  • Liu ZW, 2017, ONCOL REP, V38, P2796, DOI 10.3892/or.2017.5936
  • Lopez R, 2006, INT J GYNECOL CANCER, V16, P1289, DOI 10.1111/j.1525-1438.2006.00603.x
  • Lu YH, 2011, MINI-REV MED CHEM, V11, P611, DOI 10.2174/138955711795906923
  • Luo HR, 2019, J CELL BIOCHEM, V120, P13487, DOI 10.1002/jcb.28622
  • Lv XJ, 2019, EUR REV MED PHARMACO, V23, P1947, DOI 10.26355/eurrev_201903_17233
  • Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054
  • Makabe T, 2019, CARCINOGENESIS, V40, P611, DOI 10.1093/carcin/bgz046
  • Malakar P, 2019, CANCER RES, V79, P2480, DOI 10.1158/0008-5472.CAN-18-1432
  • Malek R, 2017, CANCER RES, V77, P3181, DOI 10.1158/0008-5472.CAN-16-2797
  • Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346
  • Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965
  • MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733
  • Marciano R, 2019, CANCERS, V11, DOI 10.3390/cancers11020156
  • Marin-Muller C, 2013, CLIN CANCER RES, V19, P5901, DOI 10.1158/1078-0432.CCR-12-3776
  • Marra L, 2013, CURR MED CHEM, V20, P833 .
  • Martinez-Fernandez M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0141-x
  • Milech N, 2010, LEUKEMIA RES, V34, P358, DOI 10.1016/j.leukres.2009.06.003
  • Moghbeli Meysam, 2016, J Gastrointest Cancer, V47, P273, DOI 10.1007/s12029-016-9824-6
  • Mohr S, 2017, CANCER CELL, V31, P549, DOI 10.1016/j.ccell.2017.03.001
  • Montavon C, 2012, GYNECOL ONCOL, V124, P582, DOI 10.1016/j.ygyno.2011.11.026
  • Morgan R, 2012, BREAST CANCER RES TR, V136, P389, DOI 10.1007/s10549-012-2259-2
  • Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89
  • MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434
  • Mudgapalli N, 2019, MOL ASPECTS MED, V70, P21, DOI 10.1016/j.mam.2019.10.001
  • Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768
  • Muralidhar SA, 2016, ETIOLOGY MORPHOGENES, P93
  • Musialik E, 2015, BLOOD RES, V50, P26, DOI 10.5045/br.2015.50.1.26
  • Niskakoski A, 2014, EPIGENETICS-US, V9, P1577, DOI 10.4161/15592294.2014.983374
  • Norgaard M, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0742-x
  • Okada S, 2015, J ORAL PATHOL MED, V44, P115, DOI 10.1111/jop.12210
  • Okumura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102111
  • Palma CA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-79
  • Pan J, 2016, BIOMED PHARMACOTHER, V77, P176, DOI 10.1016/j.biopha.2015.12.012
  • Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124288
  • Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517
  • Patel AV, 2016, EBIOMEDICINE, V9, P110, DOI 10.1016/j.ebiom.2016.06.007
  • Paul S, 2020, SEMIN CELL DEV BIOL, V100, P52, DOI 10.1016/j.semcdb.2019.10.003
  • Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4
  • Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005
  • PEVERALI FA, 1990, DIFFERENTIATION, V45, P61, DOI 10.1111/j.1432-0436.1990.tb00458.x
  • Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033
  • Platais C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4622-0
  • Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857
  • Polson ES, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2718
  • Pontikakis S, 2017, PHARMACOGENOMICS J, V17, P506, DOI 10.1038/tpj.2016.63
  • Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092
  • Qiu Y, 2012, J ZHEJIANG UNIV-SC B, V13, P168, DOI 10.1631/jzus.B1100077
  • Qiu Y, 2009, CANCER SCI, V100, P1198, DOI 10.1111/j.1349-7006.2009.01156.x
  • Qiu ZS, 2019, ACTA BIOCH BIOPH SIN, V51, P997, DOI 10.1093/abbs/gmz096
  • Rad A, 2016, TUMOR BIOL, V37, P1715, DOI 10.1007/s13277-015-3780-9
  • Ramberg H, 2016, INT J CANCER, V139, P1810, DOI 10.1002/ijc.30220
  • Ramberg H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-50
  • Rattay K, 2016, J AUTOIMMUN, V67, P65, DOI 10.1016/j.jaut.2015.10.001
  • Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104
  • REDLINE RW, 1994, LAB INVEST, V71, P663 .
  • Renganathan A, 2017, ADV EXP MED BIOL, V1008, P199, DOI 10.1007/978-981-10-5203-3_7
  • Richter GHS, 2013, J PATHOL, V230, P70, DOI 10.1002/path.4170
  • Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6
  • Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111
  • Sarayloo F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225186
  • Sarno JL, 2005, J CLIN ENDOCR METAB, V90, P522, DOI 10.1210/jc.2004-0817
  • Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088
  • Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371
  • Schussel J, 2013, CLIN CANCER RES, V19, P3268, DOI 10.1158/1078-0432.CCR-12-3496
  • Shanmugam K, 1999, MOL CELL BIOL, V19, P7577
  • Shears L, 2008, J UROLOGY, V180, P2196, DOI 10.1016/j.juro.2008.07.018
  • Shen WF, 1999, MOL CELL BIOL, V19, P3051
  • Shi JG, 2018, INT J ONCOL, V52, P179, DOI 10.3892/ijo.2017.4201
  • Shi SM, 2017, INT J MOL MED, V39, P479, DOI 10.3892/ijmm.2017.2851
  • Shiraishi K, 2007, ONCOGENE, V26, P339, DOI 10.1038/sj.onc.1209800
  • Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011
  • Sitwala KV, 2008, INT J CLIN EXP PATHO, V1, P461
  • Somers K, 2019, ONCOGENE, V38, P3824, DOI 10.1038/s41388-018-0666-5
  • Somers K, 2016, ONCOTARGET, V7, P46067, DOI 10.18632/oncotarget.10022
  • Song F, 2017, ONCOTARGET, V8, P90050, DOI 10.18632/oncotarget.21376
  • Sonnet W, 2012, DEV DYNAM, V241, P1827, DOI 10.1002/dvdy.23873
  • Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408
  • St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007
  • Staffas A, 2017, ONCOGENE, V36, P1516, DOI 10.1038/onc.2016.318
  • Stewart SL, 2013, J WOMENS HEALTH, V22, P651, DOI 10.1089/jwh.2013.4465
  • Sun JC, 2015, GENET MOL RES, V14, P18110, DOI 10.4238/2015.December.22.37
  • Sun X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.269
  • Sun YP, 2019, EXP THER MED, V17, P639, DOI 10.3892/etm.2018.7026
  • Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109
  • Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024
  • Tang L, 2019, PEERJ, V7, DOI 10.7717/peerj.6607
  • Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247
  • Thiaville MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036054
  • Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283
  • Thomsen CB, 2019, PHARMACOL RES, V141, P392, DOI 10.1016/j.phrs.2019.01.017
  • Tomoeda M, 2011, BIOCHEM BIOPH RES CO, V410, P798, DOI 10.1016/j.bbrc.2011.06.066
  • Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5
  • Tsuboi M, 2017, J BIOL CHEM, V292, P17681, DOI 10.1074/jbc.M116.772780
  • Turan RD, 2020, SCI REPORTS, V10, P1 .
  • Uchida K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-353
  • Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
  • Uribe RA, 2015, MOL BIOL CELL, V26, P3728, DOI 10.1091/mbc.E15-02-0112
  • Vastrad B, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1043-x
  • Vlachakis N, 2001, DEVELOPMENT, V128, P1299
  • von Burstin J, 2017, MOL CARCINOGEN, V56, P936, DOI 10.1002/mc.22547
  • Vriens MR, 2011, CANCER-AM CANCER SOC, V117, P259, DOI 10.1002/cncr.25369
  • Vukovic M, 2015, J EXP MED, V212, P2223, DOI 10.1084/jem.20150452
  • Wan Z, 2019, ONCOL REP, V42, P213, DOI 10.3892/or.2019.7161
  • Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006
  • Wang H, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1371-0
  • Wang HT, 2018, STEM CELL REP, V10, P447, DOI 10.1016/j.stemcr.2017.12.017
  • Wang J., 2018, IEEE T SMART GRID, V9, P1
  • Wang K, 2017, J CELL MOL MED, V21, P3730, DOI 10.1111/jcmm.13282
  • Wang M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38435-0
  • Wang MG, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1074-z
  • Wang TS, 2018, USA Patent, Patent No. [US20180118688A1, 20180118688]
  • Wang X, 2017, ONCOTARGET, V8, P63935, DOI 10.18632/oncotarget.19212
  • Wang XJ, 2019, J CELL PHYSIOL, V234, P18180, DOI 10.1002/jcp.28451
  • Wang YP, 2019, ENDOCR PATHOL, V30, P262, DOI 10.1007/s12022-019-09589-y
  • Wang YP, 2018, PATHOL RES PRACT, V214, P1340, DOI 10.1016/j.prp.2017.07.031
  • Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139
  • Watanabe Y, 2018, ONCOL LETT, V15, P2756, DOI 10.3892/ol.2017.7650
  • Wei GF, 2018, EUR J MED CHEM, V157, P759, DOI 10.1016/j.ejmech.2018.08.036
  • Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17
  • Wermuth PJ, 2005, BLOOD, V105, P1222, DOI 10.1182/blood-2004-03-0802
  • Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107
  • Wouters J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0851-3
  • Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104
  • Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114
  • Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45
  • Xavier-Magalhaes Ana, 2018, Oncotarget, V9, P15740, DOI 10.18632/oncotarget.24597
  • Xia N, 2019, EUR REV MED PHARMACO, V23, P513, DOI 10.26355/eurrev_201901_16863
  • Xiao FM, 2014, EUR J CANCER, V50, P1541, DOI 10.1016/j.ejca.2014.01.024
  • Xie RH, 2019, CANCER LETT, V449, P31, DOI 10.1016/j.canlet.2019.01.041
  • Xing BL, 2015, GENET MOL RES, V14, P4532, DOI 10.4238/2015.May.4.11
  • Xu X., 2018, FRONTIERS ED, V3, P1, DOI [10.3389/feduc.2018.00001, DOI 10.3389/FEDUC.2018.00001]
  • Yang C, 2016, EUR J GYNAECOL ONCOL, V37, P469, DOI 10.12892/ejgo3131.2016
  • Yang NL, 2017, ONCOL REP, V37, P2611, DOI 10.3892/or.2017.5514
  • Yang Nicole J, 2015, Methods Mol Biol, V1266, P29, DOI 10.1007/978-1-4939-2272-7_3
  • Yang PY, 2019, CANCER MANAG RES, V11, P8167, DOI 10.2147/CMAR.S209904
  • Yarian F, 2019, J CELL PHYSIOL, V234, P16724, DOI 10.1002/jcp.28490
  • Yeasmin S, 2010, GYNECOL ONCOL, V117, P409, DOI 10.1016/j.ygyno.2010.03.004
  • Yuan RS, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170169
  • Zha Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.370
  • Zhan FB, 2019, YONSEI MED J, V60, P163, DOI 10.3349/ymj.2019.60.2.163
  • Zhang B, 2018, ONCOL RES, V26, P37, DOI 10.3727/096504017X14900530835262
  • Zhang HJ, 2019, MED SCI MONITOR, V25, P2221, DOI 10.12659/MSM.913609
  • Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602
  • Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030
  • Zhang YF, 2017, EXP THER MED, V13, P2274, DOI 10.3892/etm.2017.4231
  • Zhang Y, 2013, BIOCHEM BIOPH RES CO, V440, P652, DOI 10.1016/j.bbrc.2013.09.121
  • Zheng DH, 2018, EUR REV MED PHARMACO, V22, P7798, DOI 10.26355/eurrev_201811_16404
  • Zhou J, 2014, LEUKEMIA, V28, P1436, DOI 10.1038/leu.2013.384
  • Zhu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3155-2
  • Zhu XL, 2012, ASIAN PAC J CANCER P, V13, P4607, DOI 10.7314/APJCP.2012.13.9.4607
  • Zhuang SF, 2019, J CELL BIOCHEM, V120, P13392, DOI 10.1002/jcb.28614
  • ZUTTER M, 1990, P NATL ACAD SCI USA, V87, P3161, DOI 10.1073/pnas.87.8.3161